A SECRET WEAPON FOR STEM CELL BANGKOK

A double-blind, placebo-managed review used intravenous allogeneic human MSCs in fifty three submit-MI patients, with equivalent adverse events in between each teams. Ambulatory EKG confirmed lowered episodes of ventricular tachycardia, together with improved forced expiratory quantity in a single second on pulmonary purpose testing inside the team